284 related articles for article (PubMed ID: 11242803)
1. Expression of transforming growth factor beta-1 in chronic hepatitis and hepatocellular carcinoma associated with hepatitis C virus infection.
Kim HG; Chung YH; Song BC; Kim J; Yang SH; Lee YS; Suh DJ
Korean J Intern Med; 2000 Dec; 15(3):165-70. PubMed ID: 11242803
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus genotype 1b increases cumulative lifetime risk of hepatocellular carcinoma.
Lee MH; Yang HI; Lu SN; Jen CL; You SL; Wang LY; L'Italien G; Chen CJ; Yuan Y;
Int J Cancer; 2014 Sep; 135(5):1119-26. PubMed ID: 24482200
[TBL] [Abstract][Full Text] [Related]
3. [Investigation of the relationship between hepatitis c virus (HCV) genotypes with HCV-RNA and alanine aminotransferase levels in chronic hepatitis c patients].
Küçköztaş MF; Ozgünes N; Yazici S
Mikrobiyol Bul; 2010 Jan; 44(1):111-5. PubMed ID: 20455406
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus genotypes and the development of hepatocellular carcinoma.
Stankovic-Djordjevic D; Djordjevic N; Tasic G; Dinic M; Karanikolic A; Pesic M
J Dig Dis; 2007 Feb; 8(1):42-7. PubMed ID: 17261134
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus seromarkers and subsequent risk of hepatocellular carcinoma: long-term predictors from a community-based cohort study.
Lee MH; Yang HI; Lu SN; Jen CL; Yeh SH; Liu CJ; Chen PJ; You SL; Wang LY; Chen WJ; Chen CJ
J Clin Oncol; 2010 Oct; 28(30):4587-93. PubMed ID: 20855826
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus genotypes in southern Taiwan: prevalence and clinical implications.
Lee CM; Lu SN; Hung CH; Tung WC; Wang JH; Tung HD; Chen CH; Hu TH; Changchien CS; Chen WJ
Trans R Soc Trop Med Hyg; 2006 Aug; 100(8):767-74. PubMed ID: 16443243
[TBL] [Abstract][Full Text] [Related]
7. The role of IDO, IL-10, and TGF-β in the HCV-associated chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma.
Yang R; Gao N; Chang Q; Meng X; Wang W
J Med Virol; 2019 Feb; 91(2):265-271. PubMed ID: 29611873
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus genotypes in patients with hepatocellular carcinoma.
Akkiz H; Colakoğlu S; Köksal F; Korkut H; Hafta A
J Environ Pathol Toxicol Oncol; 1996; 15(2-4):85-8. PubMed ID: 9216790
[TBL] [Abstract][Full Text] [Related]
9. The role of the tumor necrosis factor (TNF)--Fas L and HCV in the development of hepatocellular carcinoma.
Nada O; Abdel-Hamid M; Ismail A; El Shabrawy L; Sidhom KF; El Badawy NM; Ghazal FA; El Daly M; El Kafrawy S; Esmat G; Loffredo CA
J Clin Virol; 2005 Oct; 34(2):140-6. PubMed ID: 16157266
[TBL] [Abstract][Full Text] [Related]
10. The relationship of histologic activity to serum ALT, HCV genotype and HCV RNA titers in chronic hepatitis C.
Lee YS; Yoon SK; Chung ES; Bae SH; Choi JY; Han JY; Chung KW; Sun HS; Kim BS; Kim BK
J Korean Med Sci; 2001 Oct; 16(5):585-91. PubMed ID: 11641527
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus infection and risk of hepatocellular carcinoma among Japanese: possible role of type 1b (II) infection.
Tanaka K; Ikematsu H; Hirohata T; Kashiwagi S
J Natl Cancer Inst; 1996 Jun; 88(11):742-6. PubMed ID: 8637028
[TBL] [Abstract][Full Text] [Related]
12. The toll-like receptor 2 (TLR2) -196 to -174 del/ins polymorphism affects viral loads and susceptibility to hepatocellular carcinoma in chronic hepatitis C.
Nischalke HD; Coenen M; Berger C; Aldenhoff K; Müller T; Berg T; Krämer B; Körner C; Odenthal M; Schulze F; Grünhage F; Nattermann J; Sauerbruch T; Spengler U
Int J Cancer; 2012 Mar; 130(6):1470-5. PubMed ID: 21500195
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus genotypes and viremia and hepatocellular carcinoma in the United States.
Reid AE; Koziel MJ; Aiza I; Jeffers L; Reddy R; Schiff E; Lau JY; Dienstag JL; Liang TJ
Am J Gastroenterol; 1999 Jun; 94(6):1619-26. PubMed ID: 10364034
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus genotypes and development of hepatocellular carcinoma.
Yotsuyanagi H; Koike K; Yasuda K; Moriya K; Hino K; Kurokawa K; Iino S
Cancer; 1995 Oct; 76(8):1352-5. PubMed ID: 8620408
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus genotyping in relation to neu-oncoprotein overexpression and the development of hepatocellular carcinoma.
Zekri AN; Bahnassy AA; Shaarawy SM; Mansour OA; Maduar MA; Khaled HM; El-Ahmadi O
J Med Microbiol; 2000 Jan; 49(1):89-95. PubMed ID: 10628830
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular carcinoma in Sweden: its association with viral hepatitis, especially with hepatitis C viral genotypes.
Widell A; Verbaan H; Wejstål R; Kaczynski J; Kidd-Ljunggren K; Wallerstedt S
Scand J Infect Dis; 2000; 32(2):147-52. PubMed ID: 10826899
[TBL] [Abstract][Full Text] [Related]
17. Th1 and Th2 cytokine profiles induced by hepatitis C virus F protein in peripheral blood mononuclear cells from chronic hepatitis C patients.
Yue M; Deng X; Zhai X; Xu K; Kong J; Zhang J; Zhou Z; Yu X; Xu X; Liu Y; Zhu D; Zhang Y
Immunol Lett; 2013 May; 152(2):89-95. PubMed ID: 23680070
[TBL] [Abstract][Full Text] [Related]
18. Serum hepatitis C virus titers in the progression of type C chronic liver disease. With special emphasis on patients with type 1b infection.
Kao JH; Lai MY; Chen PJ; Hwang LH; Chen DS
J Clin Gastroenterol; 1996 Dec; 23(4):280-3. PubMed ID: 8957730
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus 1b(II) infection and development of chronic hepatitis, liver cirrhosis and hepatocellular carcinoma: a case-control study in Japan.
Tanaka H; Tsukuma H; Yamano H; Okubo Y; Inoue A; Kasahara A; Hayashi N
J Epidemiol; 1998 Oct; 8(4):244-9. PubMed ID: 9816816
[TBL] [Abstract][Full Text] [Related]
20. Role of TGF-β1 and C-Kit Mutations in the Development of Hepatocellular Carcinoma in Hepatitis C Virus-Infected Patients: in vitro Study.
El-Houseini ME; Ismail A; Abdelaal AA; El-Habashy AH; Abdallah ZF; Mohamed MZ; El-Hadidi M; Cho WCS; Ahmed H; Al-Shafie TA
Biochemistry (Mosc); 2019 Aug; 84(8):941-953. PubMed ID: 31522676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
